<ѻýҕl>With Supplements, ADT in Prostate Cancer of Little Threat to Bone Densityѻýҕl> Study suggests calcium/vitamin D alone sufficient for long-duration therapy Jun 03, 2021
<ѻýҕl>Vaccination, Screening Succeeds in Cervical and Prostate Cancersѻýҕl> Cervical cancer rates on the decline; PSA testing benefits younger Black men May 19, 2021
<ѻýҕl>SBRT Safe for Cancer Patients With Multiple Metastasesѻýҕl> Late adverse events in phase I trial indicate need for extended follow-up May 03, 2021
<ѻýҕl>Treatment Type a Non-Factor in Prostate Cancer Patients' Anxietyѻýҕl> Researchers emphasized importance of psychological interventions as problems arise Apr 29, 2021
<ѻýҕl>Late ADT a Problem in Prostate Cancerѻýҕl> Late dosing of LHRH agonists happens too frequently, researchers report Apr 22, 2021
<ѻýҕl>No More Men Need to Die From Transrectal Prostate Biopsiesѻýҕl> A movement toward transperineal biopsies Apr 21, 2021
<ѻýҕl>More Benefit With Taxane for Aggressive Metastatic Prostate Cancerѻýҕl> Higher clinical benefit rate with front-line cabazitaxel versus androgen receptor inhibitor Apr 12, 2021
<ѻýҕl>Mixed Results for Immunotherapy in Metastatic Prostate Cancerѻýҕl> Combination trial missed response endpoint but exceeded historical results Apr 11, 2021
<ѻýҕl>CCR Score Could Offer ADT-Free Path in Higher-Risk Prostate Cancerѻýҕl> Large proportion of intermediate- to high-risk patients could avoid aggressive therapy Feb 12, 2021
<ѻýҕl>Radionuclide Tx Wins in Third-Line Metastatic CRPCѻýҕl> Early trial shows improved PFS, response rates versus cabazitaxel Feb 11, 2021
<ѻýҕl>Hit and Miss in Castration-Resistant Prostate Cancerѻýҕl> No OS benefit with apalutamide-abiraterone, despite improved PFS Feb 11, 2021
<ѻýҕl>Brain Tumor Risk Upped With Synthetic Progestogenѻýҕl> Absolute risk still low, however, and product not currently approved in U.S. Feb 03, 2021
<ѻýҕl>Whole-Pelvis Tops Prostate-Only RT in High-Risk Diseaseѻýҕl> Practice impact may hinge on knowledge versus clinical bias Jan 28, 2021
<ѻýҕl>Is This Really Cancer?ѻýҕl> Movement builds to classify Gleason 6 prostate lesions as nonmalignant Jan 09, 2021
<ѻýҕl>PARP Inhibitors Linked With Blood Cancer Riskѻýҕl> Incidence of MDS/AML under 1%, but further investigation warranted as indications broaden Dec 28, 2020
<ѻýҕl>High-Risk Prostate Cancer Patients Can Wait 6 Months for Surgery: Studyѻýҕl> Can be considered low priority procedure during COVID-19 pandemic, researchers say Dec 08, 2020
<ѻýҕl>FDA OKs 'Game Changer' Radiotracer for Prostate Cancerѻýҕl> PET imaging drug detected metastasis at initial diagnosis, outperformed standard for PSA recurrence Dec 01, 2020
<ѻýҕl>Al Roker's Prostate Cancerѻýҕl> Morning show stalwart's diagnosis highlights discrepancies for Black men Nov 10, 2020
<ѻýҕl>Focal RT Boost in High-Risk Prostate Cancer Cuts PSA Relapseѻýҕl> Rates of biochemical relapse cut in half with boost to 95 Gy Oct 29, 2020
<ѻýҕl>COVID-19 in Health Workers; Stimulating New White Blood Cells: It's TTHealthWatch!ѻýҕl> This week's topics also include gene expression and COVID infection, and outbreaks in childcare settings Sep 19, 2020 podcast
<ѻýҕl>Surgery Rates Doubled for High-Risk Prostate Cancerѻýҕl> Use of prostatectomy nearly equaled radiotherapy in 2016 Aug 31, 2020
<ѻýҕl>Lower COVID-19 Risk With ADT for Prostate Cancerѻýҕl> Higher risk of infection, more severe disease in men who did not receive hormones Aug 14, 2020
<ѻýҕl>The Serious Conversation: Delivering Bad News by Telemedicineѻýҕl> As office visits move online, clinicians discuss breaking life-changing diagnoses virtually Jul 13, 2020
<ѻýҕl>Oral ADT Slashes Heart Risk in Advanced Prostate Cancerѻýҕl> Novel GnRH antagonist has potential to be new standard, says researcher May 30, 2020
<ѻýҕl>Studies Make Case for Hormonal Therapy in nmCRPCѻýҕl> Prolonged survival with three different androgen signaling inhibitors May 30, 2020
<ѻýҕl>HCQ Linked to Harm in Cancer Patientsѻýҕl> Combination with azithromycin associated with three-fold risk of mortality, registry study shows May 28, 2020
<ѻýҕl>BMI, Weight Change Linked to Prostate Ca Outcomesѻýҕl> Gain or loss of body weight both show risk May 07, 2020
<ѻýҕl>DOAC Works in Cancer-Related VTE, No Tradeoff in Bleedsѻýҕl> Apixaban monotherapy matches dalteparin in non-inferiority trial Mar 29, 2020
<ѻýҕl>Bell Ringing Not So Joyous for Cancer Patients?ѻýҕl> Greater treatment-related distress for those who rang bell at end of treatment Feb 10, 2020
<ѻýҕl>'Shock Jock' Don Imus: Not Your Usual Role Modelѻýҕl> Often despicable on-air, sure, but his approach to prostate cancer worth emulating Jan 03, 2020
<ѻýҕl>Prostate Cancer and the Waiting Gameѻýҕl> Active surveillance isn't just about avoiding surgery -- it's also buying time Dec 27, 2019
<ѻýҕl>Beta Blockers No Help in Advanced Prostate Cancerѻýҕl> Findings question earlier retrospective data that pointed to possible survival benefit Dec 05, 2019
<ѻýҕl>Docetaxel First May Boost Survival in mCRPCѻýҕl> Superior outcomes observed versus approach where chemo follows newer agents Dec 05, 2019
<ѻýҕl>MRI-Guided Ultrasound Zaps Low-Risk Prostate Cancerѻýҕl> TULSA devices achieves prostate volume reduction Dec 04, 2019
<ѻýҕl>Why the Lower Risk of Prostate Cancer in Men With Diabetes?ѻýҕl> Findings from large cohort study do not support one leading hypothesis, researchers say Nov 06, 2019
<ѻýҕl>Low T Therapy After Prostate Ca Surgery Appears Safeѻýҕl> But long-term data still lacking Oct 28, 2019
<ѻýҕl>In Memory of Gerald Chodak, MDѻýҕl> Pioneer of active surveillance for men with low-risk prostate cancer died last week Oct 03, 2019
<ѻýҕl>New Standard in Third-Line Metastatic CRPCѻýҕl> Cabazitaxel tops more anti-androgen in patients with "short-ish" response to abiraterone or enzalutamide Oct 01, 2019
<ѻýҕl>How Often Does MRI Miss the Mark in Prostate Ca?ѻýҕl> Retrospective study finds 21% of patients with prostate cancer pathology did not have ROI on MRI Sep 25, 2019